750 related articles for article (PubMed ID: 33583058)
21. Rufinamide add-on therapy for drug-resistant epilepsy.
Panebianco M; Prabhakar H; Marson AG
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011772. PubMed ID: 33179247
[TBL] [Abstract][Full Text] [Related]
22. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
[TBL] [Abstract][Full Text] [Related]
24. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
[TBL] [Abstract][Full Text] [Related]
25. Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD).
Xiong T; Chen H; Luo R; Mu D
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD010922. PubMed ID: 27737490
[TBL] [Abstract][Full Text] [Related]
26. Intravenous secretin for autism spectrum disorders (ASD).
Williams K; Wray JA; Wheeler DM
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003495. PubMed ID: 22513913
[TBL] [Abstract][Full Text] [Related]
27. Interventions based on the Theory of Mind cognitive model for autism spectrum disorder (ASD).
Fletcher-Watson S; McConnell F; Manola E; McConachie H
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD008785. PubMed ID: 24652601
[TBL] [Abstract][Full Text] [Related]
28. Parent-mediated communication interventions for improving the communication skills of preschool children with non-progressive motor disorders.
Pennington L; Akor WA; Laws K; Goldbart J
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012507. PubMed ID: 30040119
[TBL] [Abstract][Full Text] [Related]
29. d-Cycloserine enhances durability of social skills training in autism spectrum disorder.
Wink LK; Minshawi NF; Shaffer RC; Plawecki MH; Posey DJ; Horn PS; Adams R; Pedapati EV; Schaefer TL; McDougle CJ; Swiezy NB; Erickson CA
Mol Autism; 2017; 8():2. PubMed ID: 28138381
[TBL] [Abstract][Full Text] [Related]
30. Overall prognosis of preschool autism spectrum disorder diagnoses.
Brignell A; Harwood RC; May T; Woolfenden S; Montgomery A; Iorio A; Williams K
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012749. PubMed ID: 36169177
[TBL] [Abstract][Full Text] [Related]
31. A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder.
Urbano M; Okwara L; Manser P; Hartmann K; Herndon A; Deutsch SI
Clin Neuropharmacol; 2014; 37(3):69-72. PubMed ID: 24824660
[TBL] [Abstract][Full Text] [Related]
32. Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic review.
De Crescenzo F; D'Alò GL; Morgano GP; Minozzi S; Mitrova Z; Saulle R; Cruciani F; Fulceri F; Davoli M; Scattoni ML; Nardocci F; Schünemann HJ; Amato L;
Health Qual Life Outcomes; 2020 Feb; 18(1):28. PubMed ID: 32066439
[TBL] [Abstract][Full Text] [Related]
33. Interventions for childhood apraxia of speech.
Morgan AT; Murray E; Liégeois FJ
Cochrane Database Syst Rev; 2018 May; 5(5):CD006278. PubMed ID: 29845607
[TBL] [Abstract][Full Text] [Related]
34. Chelation for autism spectrum disorder (ASD).
James S; Stevenson SW; Silove N; Williams K
Cochrane Database Syst Rev; 2015 May; 5(5):CD010766. PubMed ID: 26114777
[TBL] [Abstract][Full Text] [Related]
35. Interventions for improving employment outcomes for persons with autism spectrum disorders: A systematic review update.
Fong CJ; Taylor J; Berdyyeva A; McClelland AM; Murphy KM; Westbrook JD
Campbell Syst Rev; 2021 Sep; 17(3):e1185. PubMed ID: 37052419
[TBL] [Abstract][Full Text] [Related]
36. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder.
Zimmerman AW; Singh K; Connors SL; Liu H; Panjwani AA; Lee LC; Diggins E; Foley A; Melnyk S; Singh IN; James SJ; Frye RE; Fahey JW
Mol Autism; 2021 May; 12(1):38. PubMed ID: 34034808
[TBL] [Abstract][Full Text] [Related]
37. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Williams K; Brignell A; Randall M; Silove N; Hazell P
Cochrane Database Syst Rev; 2013 Aug; (8):CD004677. PubMed ID: 23959778
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder: A Randomized Clinical Trial.
Cole J; Sohn MN; Harris AD; Bray SL; Patten SB; McGirr A
JAMA Psychiatry; 2022 Dec; 79(12):1153-1161. PubMed ID: 36223114
[TBL] [Abstract][Full Text] [Related]
39. Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder: A Randomized Clinical Trial.
Hollander E; Jacob S; Jou R; McNamara N; Sikich L; Tobe R; Smith J; Sanders K; Squassante L; Murtagh L; Gleissl T; Wandel C; Veenstra-VanderWeele J
JAMA Psychiatry; 2022 Aug; 79(8):760-769. PubMed ID: 35793101
[TBL] [Abstract][Full Text] [Related]
40. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Williams K; Wheeler DM; Silove N; Hazell P
Cochrane Database Syst Rev; 2010 Aug; (8):CD004677. PubMed ID: 20687077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
